Canver Bethany R., Newman Richard K., Gomez Anna E.
UC Davis Medical Center
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), alcohol is the most commonly used substance in the United States, with over 75% of individuals aged 12 and older reporting lifetime consumption. Alcohol consumption spans a spectrum ranging from low risk to severe alcohol use disorder (AUD). Chronic risky drinking or the presence of AUD increases the risk of alcohol withdrawal syndrome. Alcohol withdrawal syndrome poses a significant clinical challenge arising from the spectrum of AUD—a prevalent condition affecting a substantial portion of the United States population. Although most cases of alcohol withdrawal syndrome are mild and do not necessitate medical intervention, severe presentations can lead to life-threatening complications and require urgent intervention across multiple healthcare settings. Treatment can occur in various settings, such as the emergency room, outpatient clinic, intensive care unit, or detoxification facility. Consequently, the interprofessional healthcare team must ascertain the most suitable setting based on a patient’s symptoms. Following alcohol cessation, alcohol withdrawal syndrome typically presents as minor symptoms such as mild anxiety, headache, gastrointestinal discomfort, and insomnia. This syndrome can further progress to severe manifestations, such as alcohol withdrawal delirium, which poses significant diagnostic and management challenges. Mild symptoms may progress to alcohol hallucinosis, characterized by visual or auditory hallucinations that usually subside within 48 hours after alcohol cessation. Withdrawal seizures can occur in patients within just a few hours of alcohol cessation. Alcohol withdrawal delirium, formerly known as delirium tremens, is the most severe manifestation of alcohol withdrawal syndrome, characterized by symptoms such as fever, tachycardia, agitation, diaphoresis, hallucinations, disorientation, and hypertension. Patients are at risk of experiencing alcohol withdrawal delirium anywhere from 3 to 8 days following alcohol cessation. While only approximately 3% to 5% of patients with alcohol withdrawal syndrome will progress to alcohol withdrawal delirium, this condition may prove fatal. Identifying patients at risk for alcohol withdrawal delirium through a validated tool and considering the patient’s history of complicated withdrawal is a crucial aspect of managing the syndrome.
根据美国国立酒精滥用与酒精中毒研究所(NIAAA)的数据,酒精是美国最常用的物质,12岁及以上的人群中超过75%报告有终生饮酒经历。饮酒范围涵盖从低风险到严重酒精使用障碍(AUD)的一系列情况。长期危险饮酒或存在酒精使用障碍会增加酒精戒断综合征的风险。酒精戒断综合征带来了重大的临床挑战,这源于酒精使用障碍的范围——一种影响美国相当一部分人口的普遍病症。虽然大多数酒精戒断综合征病例较为轻微,无需医疗干预,但严重的症状可能导致危及生命的并发症,需要在多个医疗环境中进行紧急干预。治疗可以在各种环境中进行,如急诊室、门诊诊所、重症监护病房或戒毒设施。因此,跨专业医疗团队必须根据患者的症状确定最合适的治疗环境。戒酒之后,酒精戒断综合征通常表现为轻微症状,如轻度焦虑、头痛、胃肠道不适和失眠。这种综合征可能会进一步发展为严重表现,如酒精戒断谵妄,这带来了重大的诊断和管理挑战。轻微症状可能发展为酒精幻觉症,其特征是视觉或听觉幻觉,通常在戒酒48小时内消退。戒断性癫痫发作可能在患者戒酒几小时内发生。酒精戒断谵妄,以前称为震颤谵妄,是酒精戒断综合征最严重的表现,其特征症状包括发热、心动过速、烦躁不安、出汗、幻觉、定向障碍和高血压。患者在戒酒3至8天内有发生酒精戒断谵妄的风险。虽然只有约3%至5%的酒精戒断综合征患者会发展为酒精戒断谵妄,但这种情况可能是致命的。通过经过验证的工具识别有酒精戒断谵妄风险的患者,并考虑患者复杂戒断的病史,是管理该综合征的关键方面。